Soy Foods Linked to Better Kidney Markers in Japanese Adults With Diabetes, But Causation Remains Unproven

The natto gap was big, but the five-year follow-up found nothing significant
Daily natto eaters had far less reduced kidney function, yet fully adjusted follow-up showed no significant link to decline.
Mark

So what's the plain takeaway? Soy and healthier kidneys?

Mimi

People with diabetes who ate more natto, tofu, and miso soup were less likely to have reduced kidney function at the time they were measured. The natto gap was big: 9.2% versus 21.2%.

Luke

But that's a snapshot. It says who had what, not what the food did.

Mark

Why does the group of natto eaters matter so much?

Mimi

They also exercised more, ate more vegetables and fiber, had lower BMI, and smoked less. Healthy habits cluster.

Luke

The researchers adjusted for many of those things, but adjustment only covers what was measured and reported accurately. The diet data came from a self-completed questionnaire.

Mark

Did the associations survive the adjustments?

Mimi

Partly. Reduced kidney function held up for natto and miso soup, but tofu lost significance, and the albuminuria links for natto and isoflavones faded.

Luke

And the five-year follow-up is the key test for decline over time. After full adjustment, nothing was statistically significant. That's not proof of no effect, but it removes the strongest support.

Mark

So what would settle it?

Mimi

Randomized trials, objective intake measures, repeated diet assessments, and more diverse populations.

Luke

Also worth saying: the mechanisms like inflammation or gut microbiome were not tested here. Those are hypotheses from other studies.

  • Daily natto eaters with type 2 diabetes showed a prevalence of reduced kidney function of 9.2%, against 21.2% among those who never ate it.
  • The headline gap narrowed as researchers accounted for habits like exercise, lower smoking and more vegetables that often travel alongside soy.
  • The tofu link to reduced kidney function lost statistical significance under further adjustment, and albuminuria associations weakened across the board.
  • Across a median five years of follow-up, the protective trend for kidney decline disappeared once baseline health was accounted for.
  • The findings sit at the observational stage, and the team is calling for randomized trials and more diverse populations before any preventive claim can stand.

In a large group of Japanese adults living with type 2 diabetes, those who regularly ate soy foods such as natto, tofu and miso soup tended to have healthier kidneys, a pattern that echoes a long human hope that ordinary daily food might guard the body against slow damage. Researchers at Kyushu University and a Fukuoka diabetes clinic drew this picture from their registry, but the picture softened as they looked more closely, since people who eat soy often live in other healthy ways too. Over five years of follow-up the trend did not hold firm, leaving the relationship suggestive rather than settled. The question of whether a bowl of miso or a serving of natto can truly protect the kidneys remains open, awaiting the slower, more careful work that only controlled trials can provide.

Among 4,922 Japanese adults with type 2 diabetes, those who ate natto every day were far less likely to show reduced kidney function than those who never touched it. After adjusting for age and sex, the rates were 9.2% against 21.2%. The numbers come from a new study drawing on the Fukuoka Diabetes Registry, published in the Journal of Diabetes Investigation by researchers at Kyushu University and Hakujyuji Hospital's diabetes center.

The participants were adults receiving routine diabetes care between 2008 and 2010. Each completed a brief diet questionnaire covering miso soup, natto, tofu, and the soy compounds genistein and daidzein. Blood and urine tests then measured kidney function and protein leakage, giving the team a snapshot of each person's health.

The picture grew less tidy as the researchers looked closer. People who ate natto often also tended to be more active, eat more vegetables, weigh less and smoke less, so the foods may simply be travelling with other good habits. After further adjustment, the miso and natto links to reduced kidney function held, but the tofu finding faded, and most associations with protein in the urine lost their significance.

The team also tracked participants for a median of five years. Among 424 people who reached a serious kidney outcome, the apparent protective trend vanished once baseline health was accounted for. The authors note that laboratory work hints at mechanisms, from blood pressure hormones to gut bacteria, but this study tested none of them. Its message is modest: a promising pattern, not proof, and the answer will come from randomized trials.

Among 4,922 Japanese adults with type 2 diabetes, the people who ate natto every day were far less likely to have reduced kidney function than the people who never ate it. After adjusting for age and sex, the prevalence was 9.2% in daily natto eaters and 21.2% in non-consumers. That gap is the headline of a new study from the Fukuoka Diabetes Registry, but it is not the whole story.

The research came from the Department of Medicine and Clinical Science at Kyushu University Graduate School of Medical Sciences and the Diabetes Center at Hakujyuji Hospital in Fukuoka. It was published in the Journal of Diabetes Investigation. The participants were adults aged 20 or older who were receiving routine care from diabetes specialists between April 2008 and October 2010. The team excluded people with type 1 diabetes, medication-related diabetes, current steroid use, renal replacement therapy, or serious unrelated illnesses such as advanced cancer or decompensated liver cirrhosis.

Each participant completed a brief self-administered diet history questionnaire covering miso soup and natto (fermented soy), tofu (non-fermented soy), and the isoflavones genistein and daidzein. The team also estimated intake of protein, energy, fiber, sodium, and vegetables. Blood samples measured HbA1c, cystatin C, and creatinine, and urine samples gave the albumin-to-creatinine ratio. Reduced kidney function was defined as a cystatin C-based eGFR below 60 mL per minute per 1.73 m². Albuminuria was defined as a ratio of 30 mg per g or higher.

Frequent consumers of tofu, miso soup, and natto all had a lower prevalence of reduced eGFR than non-consumers. Higher isoflavone intake was linked to a lower prevalence of both reduced kidney function and albuminuria. Natto frequency was also inversely related to albuminuria in the primary analysis, while tofu and miso soup showed no statistically significant association with albuminuria.

The picture got less tidy under further adjustment. People who ate natto often also tended to be more physically active, eat more vegetables and fiber, weigh less, and smoke less, so the foods may be traveling with other healthy habits. When the researchers adjusted for other dietary factors, the link between natto, miso soup, and reduced kidney function generally held, but the tofu finding lost statistical significance. The isoflavone and natto associations with albuminuria also fell below significance. Sensitivity analyses using creatinine-based eGFR gave broadly similar results.

The team also followed participants over time. Of 4,802 people analyzed, 424 reached a composite outcome: at least a 40% drop in creatinine-based eGFR, the start of renal replacement therapy, or renal death. The median follow-up was five years. Age- and sex-adjusted incidence fell as intake of tofu, miso soup, natto, and isoflavones rose, and daily natto eaters had a lower rate than non-consumers. But once baseline kidney function, albuminuria, and other clinical factors were accounted for, none of the trends was statistically significant.

The authors point to experimental work suggesting soy could act on the renin-angiotensin system, the gut microbiome, oxidative stress, fibrosis, and kidney inflammation. This study did not examine any of those mechanisms. Because it was largely cross-sectional and observational, it cannot show that eating more soy prevents diabetic kidney disease.

The researchers say future work should include more diverse populations, objective measures of soy and isoflavone intake, repeated dietary assessments, and randomized trials, which are the route to testing whether the link is causal.

The results do not establish that increasing soy intake can prevent kidney disease, particularly because fully adjusted follow-up showed no significant associations with later kidney deterioration.
— Study authors' conclusion, as reported by News-Medical
Möchten Sie die ganze Geschichte? Das Original lesen bei News-Medical ↗
Kontakt FAQ